MK
MOOLCHAND KURMI
Novartis (India), Syngene International (India), National Institute of Pharmaceutical Education and Research
Employment
-
Novartis (India) Expert (Science and Technology)2022 - Present
-
Syngene International (India) Senior Research Investigator2017 - 2022
Education
-
National Institute of Pharmaceutical Education and Research Ph.D.2013 - 2016
-
National Institute of Pharmaceutical Education and Research M.S. (Pharm.)2011 - 2013
Projects & Funding
Projects & funding information is unavailable.
Publications (23)
- A Tribute to Professor Saranjit Singh - A Critical Thinker, Innovator, Mentor, and Educator Save
- Development of HPLC-CAD stability indicating assay method for polyethylene glycol-conjugated phospholipid (DMPE-PEG 2000) and identification of its degradation products Save
- Identification of extractables by liquid chromatography-high resolution mass spectrometry: A case study to understand the extraction profile of different disposable syringes Save
- Rapid and efficient chiral method development for lamivudine and tenofovir disoproxil fumarate fixed dose combination using ultra-high performance supercritical fluid chromatography: A design of experiment approach Save
- Stability behaviour of antiretroviral drugs and their combinations. 11: Characterization of interaction products of zidovudine and efavirenz, and evaluation of their anti HIV-1 activity, and physiochemical and ADMET properties Save
- Stability behaviour of antiretroviral drugs and their combinations. 9: Identification of incompatible excipients Save
- Characterization of solution stress degradation products of aliskiren and prediction of their physicochemical and ADMET properties Save
- Stability behaviour of antiretroviral drugs and their combinations. 8: Characterization and in-silico toxicity prediction of degradation products of efavirenz Save
- Successful development by design of experiments of a gas chromatography method for simultaneous analysis of residual solvents of classes 1 and 2 Save
- Stability behaviour of antiretroviral drugs and their combinations. 5: Characterization of novel degradation products of abacavir sulfate by mass and nuclear magnetic resonance spectrometry Save